Screening of novel Midkine binding protein by BioID2-based proximity labeling

Midkine (MK), a heparin-binding growth factor, is associated with the poor prognosis of the pediatric tumor, neuroblastoma. MK would be a druggable target as many studies showed inhibition of its function in various cancers suppressed tumor developments. To establish the therapy targeting MK, identi...

Descripción completa

Detalles Bibliográficos
Autores principales: Komata, Yosuke, Tsubota, Shoma, Sakamoto, Kazuma, Ikematsu, Shinya, Kadomatsu, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nagoya University 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438011/
https://www.ncbi.nlm.nih.gov/pubmed/34552285
http://dx.doi.org/10.18999/nagjms.83.3.495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438011/
https://www.ncbi.nlm.nih.gov/pubmed/34552285
http://dx.doi.org/10.18999/nagjms.83.3.495

Ejemplares similares